Safety and efficacy of daclizumab beta in patients with relapsing multiple sclerosis in a 5-year open-label study (EXTEND): final results following early termination.

Kappos, Ludwig; Cohan, Stanley; Arnold, Douglas L; Robinson, Randy R; Holman, Joan; Fam, Sami; Parks, Becky; Xiao, Shan; Castro-Borrero, Wanda

Kappos, Ludwig; Cohan, Stanley; Arnold, Douglas L; Robinson, Randy R; Holman, Joan; Fam, Sami; Parks, Becky; Xiao, Shan; Castro-Borrero, Wanda.

Afiliação

Kappos L; Research Center Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Departments of Medicine, Clinical Research, and Biomedicine and Biomedical Engineering, University Hospital and University of Basel, Petersgaben 4, Basel, CH-4031, Switzerland.
Cohan S; Providence Multiple Sclerosis Center, Providence Brain and Spine Institute, Providence St. Joseph Health, Portland, OR, USA.
Arnold DL; Montreal Neurological Institute, McGill University, Montreal, QC, Canada NeuroRx Research, Montreal, QC, Canada.
Robinson RR; AbbVie Inc., Redwood City, CA, USA.
Holman J; AbbVie Inc., North Chicago, IL, USA.
Fam S; Biogen, Cambridge, MA, USA.
Parks B; Biogen, Cambridge, MA, USA.
Xiao S; Biogen, Cambridge, MA, USA.
Castro-Borrero W; Biogen, Cambridge, MA, USA.